NasdaqGM - Nasdaq Real Time Price USD

SANUWAVE Health, Inc. (SNWV)

32.31
+1.00
+(3.19%)
At close: May 16 at 4:00:00 PM EDT
32.31
0.00
(0.00%)
After hours: May 16 at 4:05:10 PM EDT
Loading Chart for SNWV
  • Previous Close 31.31
  • Open 31.06
  • Bid 30.38 x 40000
  • Ask 31.00 x 40000
  • Day's Range 30.57 - 33.29
  • 52 Week Range 25.23 - 39.50
  • Volume 28,977
  • Avg. Volume 47,959
  • Market Cap (intraday) 276.432M
  • Beta (5Y Monthly) 1.25
  • PE Ratio (TTM) --
  • EPS (TTM) -6.23
  • Earnings Date Aug 11, 2025 - Aug 15, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. It also markets PACE systems that use acoustic pressure shockwaves generated by pulsed acoustic cellular expression technology to converge at selected areas for wound and orthopedic applications under the dermaPACE, Profile, and orthoPACE brand names. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

sanuwave.com

46

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SNWV

View More

Performance Overview: SNWV

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SNWV
19.67%
S&P 500 (^GSPC)
1.30%

1-Year Return

SNWV
19.67%
S&P 500 (^GSPC)
12.48%

3-Year Return

SNWV
19.67%
S&P 500 (^GSPC)
48.66%

5-Year Return

SNWV
19.67%
S&P 500 (^GSPC)
108.07%

Compare To: SNWV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SNWV

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    276.43M

  • Enterprise Value

    294.80M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.20

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    8.15

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -96.13%

  • Return on Assets (ttm)

    12.89%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    32.63M

  • Net Income Avi to Common (ttm)

    -31.37M

  • Diluted EPS (ttm)

    -6.23

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10.24M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -13.88M

Research Analysis: SNWV

View More

Company Insights: SNWV

Research Reports: SNWV

View More

People Also Watch